Matches in Nanopublications for { ?s ?p "[The authors investigated the impact of the genetic polymorphisms cytochrome P450 (CYP) family 2, subfamily D, polypeptide 6, allele 10 (CYP2D6 10) and CYP family 2, subfamily C, polypeptide 19, allele 2, 3 (CYP2C19 2, 3) on disease recurrence in patients with breast cancer who received adjuvant tamoxifen and evaluated the impact of those polymorphisms on endometrial thickness, bone mineral density (BMD), and serum total cholesterol levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP531801.RAReOsL8GKAx71BDYNn1pcDijAqjV9vDjX1dB_s3CvzpM130_assertion description "[The authors investigated the impact of the genetic polymorphisms cytochrome P450 (CYP) family 2, subfamily D, polypeptide 6, allele 10 (CYP2D6 10) and CYP family 2, subfamily C, polypeptide 19, allele 2, 3 (CYP2C19 2, 3) on disease recurrence in patients with breast cancer who received adjuvant tamoxifen and evaluated the impact of those polymorphisms on endometrial thickness, bone mineral density (BMD), and serum total cholesterol levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531801.RAReOsL8GKAx71BDYNn1pcDijAqjV9vDjX1dB_s3CvzpM130_provenance.
- NP283929.RA7t6qHPoQvFPpyH7Se7Ftijjgoapt_GqZtc3H6-qHn4U130_assertion description "[The authors investigated the impact of the genetic polymorphisms cytochrome P450 (CYP) family 2, subfamily D, polypeptide 6, allele 10 (CYP2D6 10) and CYP family 2, subfamily C, polypeptide 19, allele 2, 3 (CYP2C19 2, 3) on disease recurrence in patients with breast cancer who received adjuvant tamoxifen and evaluated the impact of those polymorphisms on endometrial thickness, bone mineral density (BMD), and serum total cholesterol levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283929.RA7t6qHPoQvFPpyH7Se7Ftijjgoapt_GqZtc3H6-qHn4U130_provenance.
- NP307767.RAX4vkvJgTFpn5Cyo7wOaMy6M5YLQ8OI-npLQs52y0eKM130_assertion description "[The authors investigated the impact of the genetic polymorphisms cytochrome P450 (CYP) family 2, subfamily D, polypeptide 6, allele 10 (CYP2D6 10) and CYP family 2, subfamily C, polypeptide 19, allele 2, 3 (CYP2C19 2, 3) on disease recurrence in patients with breast cancer who received adjuvant tamoxifen and evaluated the impact of those polymorphisms on endometrial thickness, bone mineral density (BMD), and serum total cholesterol levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307767.RAX4vkvJgTFpn5Cyo7wOaMy6M5YLQ8OI-npLQs52y0eKM130_provenance.
- NP282630.RAvyxbTnQYE15MdFYUM2bOa921u9kBSckVlSYJLgPUl2A130_assertion description "[The authors investigated the impact of the genetic polymorphisms cytochrome P450 (CYP) family 2, subfamily D, polypeptide 6, allele 10 (CYP2D6 10) and CYP family 2, subfamily C, polypeptide 19, allele 2, 3 (CYP2C19 2, 3) on disease recurrence in patients with breast cancer who received adjuvant tamoxifen and evaluated the impact of those polymorphisms on endometrial thickness, bone mineral density (BMD), and serum total cholesterol levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282630.RAvyxbTnQYE15MdFYUM2bOa921u9kBSckVlSYJLgPUl2A130_provenance.
- NP806129.RAnxYNn9HeFAuGB1yM2oSAAq6jHreb8y6inTOf5X6SJ0g130_assertion description "[The authors investigated the impact of the genetic polymorphisms cytochrome P450 (CYP) family 2, subfamily D, polypeptide 6, allele 10 (CYP2D6 10) and CYP family 2, subfamily C, polypeptide 19, allele 2, 3 (CYP2C19 2, 3) on disease recurrence in patients with breast cancer who received adjuvant tamoxifen and evaluated the impact of those polymorphisms on endometrial thickness, bone mineral density (BMD), and serum total cholesterol levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806129.RAnxYNn9HeFAuGB1yM2oSAAq6jHreb8y6inTOf5X6SJ0g130_provenance.
- NP500287.RAbiGG5Cm607tFPINCjlxTJhPwslGQcmmY8PN-Vxfjkz0130_assertion description "[The authors investigated the impact of the genetic polymorphisms cytochrome P450 (CYP) family 2, subfamily D, polypeptide 6, allele 10 (CYP2D6 10) and CYP family 2, subfamily C, polypeptide 19, allele 2, 3 (CYP2C19 2, 3) on disease recurrence in patients with breast cancer who received adjuvant tamoxifen and evaluated the impact of those polymorphisms on endometrial thickness, bone mineral density (BMD), and serum total cholesterol levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500287.RAbiGG5Cm607tFPINCjlxTJhPwslGQcmmY8PN-Vxfjkz0130_provenance.
- NP498429.RAMSULsjt82bGakoS-bycx1lxhI4lpPKkW-_ueiCjdCDU130_assertion description "[The authors investigated the impact of the genetic polymorphisms cytochrome P450 (CYP) family 2, subfamily D, polypeptide 6, allele 10 (CYP2D6 10) and CYP family 2, subfamily C, polypeptide 19, allele 2, 3 (CYP2C19 2, 3) on disease recurrence in patients with breast cancer who received adjuvant tamoxifen and evaluated the impact of those polymorphisms on endometrial thickness, bone mineral density (BMD), and serum total cholesterol levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498429.RAMSULsjt82bGakoS-bycx1lxhI4lpPKkW-_ueiCjdCDU130_provenance.